日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Safety and effectiveness of post-trastuzumab deruxtecan regimens in patients with HER2-positive metastatic breast cancer who discontinued trastuzumab deruxtecan due to interstitial lung disease

因间质性肺病而停用曲妥珠单抗德鲁替康的HER2阳性转移性乳腺癌患者，在停用曲妥珠单抗德鲁替康后，后续治疗方案的安全性和有效性

期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2026.104722
Tsurutani, Junji; Nozawa, Kazuki; Mukohara, Toru; Taira, Tetsuhiko; Yoshimura, Akiyo; Nagai, Shigenori E; Hashimoto, Jun; Matsuura, Kazuo; Mizuno, Toshiro; Shinden, Yoshiaki; Yamamoto, Mitsugu; Takano, Toshimi; Wakahara, Makoto; Terakawa, Hirofumi; Yamanaka, Takashi; Kojima, Yasuyuki; Nakayama, Takahiro; Hirakawa, Yuji; Shiosakai, Kazuhito; Iwata, Hiroji
肿瘤
特发性肺纤维化
HER2
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Effect of N-terminal pro B-type natriuretic peptide levels on the efficacy and safety of esaxerenone vs trichlormethiazide for the treatment of Japanese patients with uncontrolled essential hypertension: a subanalysis of the EXCITE-HT study

N端B型利钠肽前体水平对依沙沙酮与三氯噻嗪治疗日本未控制原发性高血压患者的疗效和安全性的影响：EXCITE-HT研究的亚组分析

期刊:Hypertension Research
影响因子:4.6
doi:10.1038/s41440-025-02412-8
Kario, Kazuomi; Ohishi, Mitsuru; Katsuya, Tomohiro; Shimosawa, Tatsuo; Shiosakai, Kazuhito; Furugori, Taketoshi; Taguchi, Takashi
心血管
高血压
发表日期：2026
文献求助 收藏

Efficacy and safety of esaxerenone vs trichlormethiazide for the treatment of uncontrolled essential hypertension in Japanese patients with type 2 diabetes mellitus: a subanalysis of the EXCITE-HT study

依沙克雷酮与三氯噻嗪治疗日本2型糖尿病合并原发性高血压患者的疗效和安全性比较：EXCITE-HT研究的亚组分析

期刊:Hypertension Research
影响因子:4.6
doi:10.1038/s41440-025-02437-z
Ohishi, Mitsuru; Kario, Kazuomi; Katsuya, Tomohiro; Shimosawa, Tatsuo; Shiosakai, Kazuhito; Furugori, Taketoshi; Taguchi, Takashi
糖尿病
心血管
高血压
代谢
发表日期：2026
文献求助 收藏

Efficacy and Safety of Mirogabalin in Patients with Neuropathic Pain Due to Cervical Spondylotic Radiculopathy: Miro-Cens, A Randomized, Controlled, Interventional Study

米罗加巴林治疗颈椎病神经根病所致神经性疼痛患者的疗效和安全性：一项随机、对照、干预性研究（Miro-Cens）

期刊:Pain and Therapy
影响因子:3.3
doi:10.1007/s40122-025-00722-w
Hirai, Takashi; Okawa, Atsushi; Takahashi, Hiroshi; Shiosakai, Kazuhito; Yoshii, Toshitaka
发表日期：2025
文献求助 收藏

Safety and Efficacy of Mirogabalin in Lumbar Spinal Stenosis Patients with Peripheral Neuropathic Pain on NSAIDs: Post Hoc Analysis of the MiroTAS Study

米罗加巴林治疗服用非甾体抗炎药的腰椎管狭窄合并周围神经性疼痛患者的安全性和有效性：MiroTAS 研究的事后分析

期刊:Pain and Therapy
影响因子:3.3
doi:10.1007/s40122-025-00732-8
Nikaido, Takuya; Tabata, Shunsuke; Shiosakai, Kazuhito; Nakatani, Taichi; Sakoda, Hiroshi
发表日期：2025
文献求助 收藏

A multicenter randomized open-label phase 2 study investigating optimal antiemetic therapy for patients with advanced/recurrent gastric cancer treated with trastuzumab deruxtecan: the EN-hance study

一项多中心、随机、开放标签的 II 期研究，旨在探讨接受曲妥珠单抗德鲁替康治疗的晚期/复发性胃癌患者的最佳止吐治疗方案：EN-hance 研究

期刊:International Journal of Clinical Oncology
影响因子:2.8
doi:10.1007/s10147-025-02748-8
Aoyama, Toru; Ooki, Akira; Oba, Koji; Nishikawa, Kazuhiro; Kawabata, Ryohei; Honda, Michitaka; Maeda, Hiromichi; Kanda, Mitsuro; Sugiyama, Keiji; Makiyama, Akitaka; Segami, Kenki; Takahashi, Masazumi; Shindo, Yoshiaki; Namikawa, Tsutomu; Oshima, Takashi; Katayama, Aya; Shiosakai, Kazuhito; Sakamoto, Junichi
胃癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

A Multicenter, Open-Label Study to Evaluate the Long-term Safety and Efficacy of Adjunctive Brexpiprazole 2 mg Daily in Japanese Patients with Major Depressive Disorder

一项多中心、开放标签研究，旨在评估每日服用2毫克布瑞哌唑辅助治疗日本重度抑郁症患者的长期安全性和有效性

期刊:CNS Drugs
影响因子:7.4
doi:10.1007/s40263-024-01124-w
Kato, Masaki; Shiosakai, Masako; Kuwahara, Kazuo; Iba, Katsuhiro; Shimada, Yuki; Saito, Mizuki; Sekine, Daisuke; Aoki, Kazuo; Shiomi, Yuki; Higuchi, Teruhiko
抑郁症
神经科学
发表日期：2024
文献求助 收藏

Efficacy and Safety of Esaxerenone in Hypertensive Patients with Left Ventricular Hypertrophy (ESES-LVH) Study: A Multicenter, Open-Label, Prospective, Interventional Study

埃沙沙酮治疗伴左心室肥厚的高血压患者的疗效和安全性（ESES-LVH）研究：一项多中心、开放标签、前瞻性干预研究

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-024-02780-6
Yamamoto, Eiichiro; Usuku, Hiroki; Sueta, Daisuke; Suzuki, Satoru; Nakamura, Taishi; Matsui, Kunihiko; Matsushita, Kenichi; Iwasaki, Tomoko; Sakaino, Naritsugu; Sakanashi, Toshihiko; Hirayama, Kazuto; Kurokawa, Hirofumi; Kikuta, Koichi; Yamamoto, Nobuyasu; Sato, Koji; Tokitsu, Takanori; Taguchi, Takashi; Shiosakai, Kazuhito; Sugimoto, Kotaro; Tsujita, Kenichi
心血管
高血压
发表日期：2024
文献求助 收藏

Efficacy and safety of add-on mirogabalin to conventional therapy for the treatment of peripheral neuropathic pain after thoracic surgery: the multicenter, randomized, open-label ADMIT-NeP study

胸外科手术后周围神经性疼痛治疗中，米罗加巴林联合常规疗法的疗效和安全性：一项多中心、随机、开放标签的ADMIT-NeP研究

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-023-11708-2
Miyazaki, Takuro; Matsumoto, Keitaro; Sato, Toshihiko; Sano, Isao; Furukawa, Katsuro; Shimoyama, Koichiro; Kamohara, Ryotaro; Suzuki, Makoto; Kondou, Masamichi; Ikeda, Norihiko; Tabata, Shunsuke; Shiosakai, Kazuhito; Nagayasu, Takeshi
发表日期：2024
文献求助 收藏

Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM)

曲妥珠单抗德鲁替康治疗伴有脑转移和/或软脑膜转移的 HER2 阳性乳腺癌患者：一项基于多中心回顾性研究 (ROSET-BM) 数据的最新总生存期分析

期刊:Breast Cancer
影响因子:2.9
doi:10.1007/s12282-024-01614-1
Nakayama, Takahiro; Niikura, Naoki; Yamanaka, Takashi; Yamamoto, Mitsugu; Matsuura, Kazuo; Inoue, Kenichi; Takahara, Sachiko; Nomura, Hironori; Kita, Shosuke; Yamaguchi, Miki; Aruga, Tomoyuki; Shibata, Nobuhiro; Shimomura, Akihiko; Ozaki, Yuri; Sakai, Shuji; Takiguchi, Daisuke; Takata, Takehiko; Bastanfard, Armin; Shiosakai, Kazuhito; Tsurutani, Junji
肿瘤
HER2
肿瘤免疫
神经科学
乳腺癌
SET
发表日期：2024
文献求助 收藏